SEC Form 4 · accession 0000874015-18-000107
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Frank Bennett
Officer — SVP, Antisense Research
Period of report
Aug 8, 2018
Accepted (ET)
Aug 9, 2018 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 8, 2018 | M | 13 | $7.25 | A | 19,409 | D | |
| Common StockF1 | Aug 8, 2018 | S | 13 | $45.00 | D | 19,396 | D | |
| Common StockF1 | Aug 8, 2018 | M | 12,487 | $14.69 | A | 31,883 | D | |
| Common StockF1 | Aug 8, 2018 | S | 12,487 | $45.00 | D | 19,396 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $7.25 | Aug 8, 2018 | M | 13 | A | Jan 3, 2016 | Jan 2, 2019 | Common Stock | 13 | 0 | D |
| Employee Stock Option (right to buy) | $14.69 | Aug 8, 2018 | M | 12,487 | A | Jan 2, 2017 | Jan 29, 2020 | Common Stock | 12,487 | 21,513 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 12/8/2017.